M Vidailhet

Summary

Country: France

Publications

  1. ncbi request reprint [Botulinum toxin in neurology]
    M Vidailhet
    Service de Neurologie, Hopital Saint Antoine, 184, rue du Faubourg St Antoine, 75571 Paris Cedex 12, France
    Rev Med Interne 26:531-3. 2005
  2. doi request reprint [Paroxysmal kinesigenic dyskinesia: a channelopathy? Study of 19 cases]
    G Fourcade
    Service de Neurologie, CHU Caremeau, place du Professeur Robert Debré, 30029 Nimes Cedex, France
    Rev Neurol (Paris) 165:164-9. 2009
  3. pmc Factors predicting improvement in motor disability in writer's cramp treated with botulinum toxin
    R Djebbari
    Department of Neurology, Hopital Saint Antoine, Paris, France
    J Neurol Neurosurg Psychiatry 75:1688-91. 2004
  4. ncbi request reprint Paroxysmal dyskinesias as a paradigm of paroxysmal movement disorders
    M Vidailhet
    Department of Neurology, Hopital Saint Antoine, and U289, Hopital de la Salpetriere, Paris, France
    Curr Opin Neurol 13:457-62. 2000
  5. ncbi request reprint Effect of gabapentin on oculomotor control and parkinsonism in patients with progressive supranuclear palsy
    A Poujois
    Service de Neurologie, CHU Saint Etienne, Saint Etienne, France
    Eur J Neurol 14:1060-2. 2007
  6. ncbi request reprint [Resolution of choreic movements associated with HIV encephalitis with anti-retroviral therapy]
    J M Trocello
    Service de Neurologie, Hopital Saint Antoine, Paris
    Rev Neurol (Paris) 162:89-91. 2006
  7. ncbi request reprint [Movement disorders and botulinum toxin in neurology]
    S Sangla
    Service de Neurologie, Hopital Saint Antoine, 184, rue du Faubourg Saint Antoine, 75571 Paris Cedex 12, France
    Ann Readapt Med Phys 46:307-11. 2003
  8. doi request reprint [Chorea, lupus and antiphospholipid antibodies]
    P Reiner
    Service de Neurologie, Hopital Lariboisiere, Universite Paris 7, AP HP, 75475 Paris Cedex 10, France
    Rev Med Interne 33:206-8. 2012
  9. ncbi request reprint [Dystonia: contributions of functional imaging and magnetoencephalography]
    S Lehericy
    Service de Neuroradiologie et INSERM EMI 007, Hopital de la Pitie Salpetriere, Paris, France
    Rev Neurol (Paris) 159:874-9. 2003
  10. ncbi request reprint [National neonatal screening program for cystic fibrosis: management and organization]
    C Grosskopf
    Association française pour le dépistage et la prévention des handicaps de l enfant, 38, rue Cauchy, 75015 Paris, France
    Arch Pediatr 10:364s-369s. 2003

Collaborators

Detail Information

Publications28

  1. ncbi request reprint [Botulinum toxin in neurology]
    M Vidailhet
    Service de Neurologie, Hopital Saint Antoine, 184, rue du Faubourg St Antoine, 75571 Paris Cedex 12, France
    Rev Med Interne 26:531-3. 2005
  2. doi request reprint [Paroxysmal kinesigenic dyskinesia: a channelopathy? Study of 19 cases]
    G Fourcade
    Service de Neurologie, CHU Caremeau, place du Professeur Robert Debré, 30029 Nimes Cedex, France
    Rev Neurol (Paris) 165:164-9. 2009
    ..The favorable natural history, the episodic nature of the symptoms and their sensitivity to anticonvulsant therapy suggest channelopathy as a mechanism of PKD...
  3. pmc Factors predicting improvement in motor disability in writer's cramp treated with botulinum toxin
    R Djebbari
    Department of Neurology, Hopital Saint Antoine, Paris, France
    J Neurol Neurosurg Psychiatry 75:1688-91. 2004
    ..To identify factors predicting improvement in motor disability in writer's cramp treated with botulinum toxin (BTX)...
  4. ncbi request reprint Paroxysmal dyskinesias as a paradigm of paroxysmal movement disorders
    M Vidailhet
    Department of Neurology, Hopital Saint Antoine, and U289, Hopital de la Salpetriere, Paris, France
    Curr Opin Neurol 13:457-62. 2000
    ..Among the paroxysmal disorders, these diseases may belong to the group of channelopathies...
  5. ncbi request reprint Effect of gabapentin on oculomotor control and parkinsonism in patients with progressive supranuclear palsy
    A Poujois
    Service de Neurologie, CHU Saint Etienne, Saint Etienne, France
    Eur J Neurol 14:1060-2. 2007
    ..This preliminary study shows that gabapentin improves reflexive saccade inhibition in patients with PSP but does not improve the latency of VGSs...
  6. ncbi request reprint [Resolution of choreic movements associated with HIV encephalitis with anti-retroviral therapy]
    J M Trocello
    Service de Neurologie, Hopital Saint Antoine, Paris
    Rev Neurol (Paris) 162:89-91. 2006
    ..Infection of the central nervous system with human immunodeficiency virus (HIV) can be associated with movement disorders...
  7. ncbi request reprint [Movement disorders and botulinum toxin in neurology]
    S Sangla
    Service de Neurologie, Hopital Saint Antoine, 184, rue du Faubourg Saint Antoine, 75571 Paris Cedex 12, France
    Ann Readapt Med Phys 46:307-11. 2003
    ..We discuss the data of literature and compare them with the experience of the French movement disorders groups...
  8. doi request reprint [Chorea, lupus and antiphospholipid antibodies]
    P Reiner
    Service de Neurologie, Hopital Lariboisiere, Universite Paris 7, AP HP, 75475 Paris Cedex 10, France
    Rev Med Interne 33:206-8. 2012
    ..They also have an excess risk of obstetric morbidity and valvular disease. The prescription of antiplatelet agents and adequate management, especially during pregnancy, can probably reduce this risk...
  9. ncbi request reprint [Dystonia: contributions of functional imaging and magnetoencephalography]
    S Lehericy
    Service de Neuroradiologie et INSERM EMI 007, Hopital de la Pitie Salpetriere, Paris, France
    Rev Neurol (Paris) 159:874-9. 2003
    ..Spectroscopic MRI may also be used to measure GABA levels, which are decreased in the cortex and basal ganglia in these patients...
  10. ncbi request reprint [National neonatal screening program for cystic fibrosis: management and organization]
    C Grosskopf
    Association française pour le dépistage et la prévention des handicaps de l enfant, 38, rue Cauchy, 75015 Paris, France
    Arch Pediatr 10:364s-369s. 2003
    ..This screening program should allow to screen 98% of the cystic fibrosis patients before the age of 1 month. In order to ensure perfect efficacy, the CF screening program will be evaluated and modified if necessary...
  11. ncbi request reprint Neonatal screening for cystic fibrosis: France rises to the challenge
    J P Farriaux
    Association française pour le dépistage et la prévention des handicaps de l enfant, Paris, France
    J Inherit Metab Dis 26:729-44. 2003
    ..The expert groups still meet periodically to evaluate the implementation of the programme and to check that the terms of the agreement between the AFDPHE and the Social Security Agency are complied with...
  12. ncbi request reprint [National program for neonatal screening for cystic fibrosis: implementation and preliminary results]
    J Navarro
    Hopital Robert Debre, AP HP, 48, boulevard Serurier, 75935 Paris Cedex 19
    J Gynecol Obstet Biol Reprod (Paris) 32:1S56-60. 2003
    ..Based on therapeutic progress and the proposed method using determination of blood immunoreactive trypsin then study of the main CF mutations, there is strong hope of effective CF detection and clinical benefit for the patients...
  13. pmc Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes
    S Tezenas du Montcel
    Service de Biostatistique et Information Medicale, Hopital Pitie Salpetriere, AP HP, Paris, France
    J Med Genet 43:394-400. 2006
    ..Myoclonus dystonia syndrome (MDS) is an autosomal dominant movement disorder caused by mutations in the epsilon-sarcoglycan gene (SGCE) on chromosome 7q21...
  14. doi request reprint Movement disorders and inborn errors of metabolism in adults: a diagnostic approach
    F Sedel
    Federation of Nervous System Diseases, Salpetriere Hospital, Assistance Publique Hopitaux de Paris, Paris, France
    J Inherit Metab Dis 31:308-18. 2008
    ....
  15. ncbi request reprint Structural abnormalities in the cerebellum and sensorimotor circuit in writer's cramp
    C Delmaire
    INSERM U610, groupe hôpitalier Pitié Salpêtrière, Universite Pierre et Marie Curie Paris 6, Paris, France
    Neurology 69:376-80. 2007
    ..Evidence in other primary dystonia, including blepharospasm and cervical dystonia, suggest that structural abnormalities may be observed in other brain areas such as the cerebellum in writer's cramp...
  16. doi request reprint [Folic acid and prevention of neural tube closure defects: the question is not solved yet]
    M Vidailhet
    Service de Pediatrie, 3, Hôpital d Enfants, CHU de Nancy, 54130 Nancy, France
    Arch Pediatr 15:1223-31. 2008
    ..As of today, despite their limited preventive efficacy, a safe approach is to keep our current French recommendations and to increase the awareness of all caregivers, so as to improve the observance of these recommendations...
  17. doi request reprint Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations
    E Roze
    Service de Neurologie, Hopital Saint Antoine, 184 rue du Faubourg Saint Antoine, 75571 Paris Cedex 12, France
    Neurology 70:1010-6. 2008
    ..To clarify the clinical and neurophysiologic spectrum of myoclonus-dystonia patients with mutations of the SGCE gene...
  18. doi request reprint Recessive hereditary methaemoglobinaemia, type II: delineation of the clinical spectrum
    C Ewenczyk
    Pôle des maladies du système nerveux, Federation de Neurologie, Groupe Hospitalier Pitie Salpetriere, AP HP, Paris, France
    Brain 131:760-1. 2008
    ..Here we report three novel mutations in the NADH-cytochrome b5 reductase gene. Prenatal diagnosis of this extremely severe disease should be proposed to affected families...
  19. ncbi request reprint [Pallidal stimulation for primary generalized dystonia]
    L Vercueil
    Rev Neurol (Paris) 161:381-3. 2005
  20. ncbi request reprint A major locus for several phenotypes of myoclonus--dystonia on chromosome 7q
    M Vidailhet
    INSERM U289, , Paris, France
    Neurology 56:1213-6. 2001
    ..5 to 38 years. Only four patients from two families had a positive response to alcohol. Lod scores were positive in all four families, suggesting that chromosome 7q21-q31 is a major locus for myoclonus-dystonia with several phenotypes...
  21. ncbi request reprint [Vitamin deficiency and malnutrition]
    I Birlouez
    Ann Biol Clin (Paris) 60:443-50. 2002
  22. ncbi request reprint [Fluoride supplementation must be initiated at birth in children in France]
    A Bocquet
    Arch Pediatr 9:1211-2. 2002
  23. pmc Mirror movements of the non-affected hand in hemiparkinsonian patients: a reflection of ipsilateral motor overactivity?
    J S Vidal
    J Neurol Neurosurg Psychiatry 74:1352-3. 2003
  24. ncbi request reprint Candidate gene studies in focal dystonia
    D Sibbing
    Department of Neurology, Philipps University, Marburg, Germany
    Neurology 61:1097-101. 2003
    ..Mutations in the DYT1 gene can cause focal dystonia, and an association with a polymorphism in the D5 receptor gene (DRD5) has been reported but not confirmed...
  25. ncbi request reprint [Symptomatic rickets in adolescents]
    E Mallet
    Département de Pédiatrie Médicale, CHU de Rouen, France
    Arch Pediatr 11:871-8. 2004
    ..Rickets affects immigrant adolescents in particular but nevertheless could also present a certain risk period for the general population...
  26. ncbi request reprint Disorganized somatotopy in the putamen of patients with focal hand dystonia
    C Delmaire
    Department of Neuroradiology, Hopital de la Pitie Salpetriere, Paris, France
    Neurology 64:1391-6. 2005
    ..To explore the selectivity of neuronal somatotopic representation in the striatum of patients with unilateral task-specific dystonia of the right arm...
  27. ncbi request reprint [Cystic fibrosis: the French neonatal screening organization, preliminary results]
    A Munck
    AFDPHE, 38, rue Cauchy, 75015 Paris, France
    Arch Pediatr 12:646-9. 2005
  28. ncbi request reprint Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?
    J Tassin
    INSERM U289, Hopital de la Salpetriere, Paris, France
    Brain 123:1112-21. 2000
    ..No mutations were identified in seven families. The clinical spectrum extended from the classical DRD phenotype to parkinsonism with levodopa-induced dyskinesias, and included spastic paraplegia as well as the absence of dystonia...